Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Ernesto Schiffrin

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Living Beings

Chemicals & Drugs

Anatomy

Physiology

Vascular Resistance

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
121
Touyz, Rhian
30
Li, JS
28
Amiri, Farhad
16
Diep, Quy
16
Thibault, Gaétan
14
Neves, Mario Fritsch
14
Park, Jeong Bae
14
Endemann, Dierk
13
Virdis, Agostino
11
Pu, Qian
11
Garcia, Raul
11
He, Gang
10
Iglarz, Marc
10
Intengan, HD
9
Fareh, J

Sign-in to see all Coauthors

Publications

TOP 3
Schiffrin Ernesto L
Jacques de Champlain, Md, PhD, FAHA, 1938-2009.
Lemarié Catherine A; Simeone Stefania M C; Nikonova Anna; Ebrahimian Talin; Deschênes Marie-Eve; Coffman Thomas M; Paradis Pierre; Schiffrin Ernesto L
Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors.
Abourbih Samuel; Filion Kristian B; Joseph Lawrence; Schiffrin Ernesto L; Rinfret Stephane; Poirier Paul; Pilote Louise; Genest Jacques; Eisenberg Mark J
Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Ernesto Schiffrin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Schiffrin Ernesto L
Jacques de Champlain, Md, PhD, FAHA, 1938-2009.
Hypertension 2009;54(4):689.
2009: Lemarié Catherine A; Simeone Stefania M C; Nikonova Anna; Ebrahimian Talin; Deschênes Marie-Eve; Coffman Thomas M; Paradis Pierre; Schiffrin Ernesto L
Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors.
Circulation research 2009;105(9):852-9.
2009: Abourbih Samuel; Filion Kristian B; Joseph Lawrence; Schiffrin Ernesto L; Rinfret Stephane; Poirier Paul; Pilote Louise; Genest Jacques; Eisenberg Mark J
Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review.
The American journal of medicine 2009;122(10):962.e1-8.
2009: Schiffrin Ernesto L; Paradis Pierre
Suppression of peroxisome proliferator-activated receptor-gamma activity by angiotensin II in vascular smooth muscle involves Bcr kinase: the fire that drowns the water.
Circulation research 2009;104(1):4-6.
2008: Ebrahimian Talin; Sairam M Ram; Schiffrin Ernesto L; Touyz Rhian M
Cardiac hypertrophy is associated with altered thioredoxin and ASK-1 signaling in a mouse model of menopause.
American journal of physiology. Heart and circulatory physiology 2008;295(4):H1481-8.
2008: Dhaun Neeraj; Goddard Jane; Kohan Donald E; Pollock David M; Schiffrin Ernesto L; Webb David J
Role of endothelin-1 in clinical hypertension: 20 years on.
Hypertension 2008;52(3):452-9.
2008: Levy Bernard I; Schiffrin Ernesto L; Mourad Jean-Jacques; Agostini Denis; Vicaut Eric; Safar Michel E; Struijker-Boudier Harry A J
Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus.
Circulation 2008;118(9):968-76.
2008: Schiffrin Ernesto L
The flame that lights the fire: oxidative stress, inflammation, and renal damage in angiotensin II-induced hypertension.
Hypertension 2008;52(2):205-6.
2008: Montezano A C; Callera G E; Yogi A; He Y; Tostes R C; He G; Schiffrin E L; Touyz R M
Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(8):1511-8.
2008: Marchesi Chiara; Paradis Pierre; Schiffrin Ernesto L
Role of the renin-angiotensin system in vascular inflammation.
Trends in pharmacological sciences 2008;29(7):367-74.
2008: Tabet Fatiha; Schiffrin Ernesto L; Callera Glaucia E; He Ying; Yao Guoying; Ostman Arne; Kappert Kai; Tonks Nicholas K; Touyz Rhian M
Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR.
Circulation research 2008;103(2):149-58.
2008: Viel Emilie C; Benkirane Karim; Javeshghani Danesh; Touyz Rhian M; Schiffrin Ernesto L
Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats.
American journal of physiology. Heart and circulatory physiology 2008;295(1):H281-8.
2008: Padwal Raj J; Hemmelgarn Brenda R; Khan Nadia A; Grover Steven; McAlister Finlay A; McKay Donald W; Wilson Thomas; Penner Brian; Burgess Ellen; Bolli Peter; Hill Michael D; Mahon Jeff; Myers Martin G; Abbott Carl; Schiffrin Ernesto L; Honos George; Mann Karen; Tremblay Guy; Milot Alain; Cloutier Lyne; Chockalingam Arun; Rabkin Simon W; Dawes Martin Dawes; Touyz Rhian M; Bell Chaim; Burns Kevin D; Ruzicka Marcel; Campbell Norman R C; Lebel Marcel; Tobe Sheldon W;
The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk.
The Canadian journal of cardiology 2008;24(6):455-63.
2008: Amiri Farhad; Paradis Pierre; Reudelhuber Timothy L; Schiffrin Ernesto L
Vascular inflammation in absence of blood pressure elevation in transgenic murine model overexpressing endothelin-1 in endothelial cells.
Journal of hypertension 2008;26(6):1102-9.
2008: Lemarié Catherine A; Paradis Pierre; Schiffrin Ernesto L
New insights on signaling cascades induced by cross-talk between angiotensin II and aldosterone.
Journal of molecular medicine (Berlin, Germany) 2008;86(6):673-8.
2008: Touyz Rhian M; Schiffrin Ernesto L
Reactive oxygen species and hypertension: a complex association.
Antioxidants & redox signaling 2008;10(6):1041-4.
2008: Leibovitz Eyal; Schiffrin Ernesto L
[New treatments in hypertension: direct renin inhibitors]
Harefuah 2008;147(3):218-23, 278.
2008: Schiffrin Ernesto L
New twist to the role of the renin-angiotensin system in heart failure: aldosterone upregulates renin-angiotensin system components in the brain.
Hypertension 2008;51(3):622-3.
2008: Savoia Carmine; Touyz Rhian M; Amiri Farhad; Schiffrin Ernesto L
Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients.
Hypertension 2008;51(2):432-9.
2008: Pu Qian; Brassard Pascal; Javeshghani Danesh M; Iglarz Marc; Webb Randy L; Amiri Farhad; Schiffrin Ernesto L
Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
Journal of hypertension 2008;26(2):322-33.
2008: Schiffrin Ernesto L
Oxidative stress, nitric oxide synthase, and superoxide dismutase: a matter of imbalance underlies endothelial dysfunction in the human coronary circulation.
Hypertension 2008;51(1):31-2.
2007: Sampaio Walkyria O; Henrique de Castro Carlos; Santos Robson A S; Schiffrin Ernesto L; Touyz Rhian M
Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells.
Hypertension 2007;50(6):1093-8.
2007: Yogi A; Callera G E; Montezano A C I; Aranha A B; Tostes R C; Schiffrin E L; Touyz R M
Endothelin-1, but not Ang II, activates MAP kinases through c-Src independent Ras-Raf dependent pathways in vascular smooth muscle cells.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(9):1960-7.
2007: Leibovitz Eyal; Schiffrin Ernesto L
PPAR activation: a new target for the treatment of hypertension.
Journal of cardiovascular pharmacology 2007;50(2):120-5.
2007: Leibovitz Eyal; Schiffrin Ernesto L
Novel drugs targeting hypertension: renin inhibitors and beyond.
Journal of cardiovascular pharmacology 2007;50(1):3-8.
2007: Schiffrin Ernesto L; Lipman Mark L; Mann Johannes F E
Chronic kidney disease: effects on the cardiovascular system.
Circulation 2007;116(1):85-97.
2007: Pandey Nihar R; Benkirane Karim; Amiri Farhad; Schiffrin Ernesto L
Effects of PPAR-gamma knock-down and hyperglycemia on insulin signaling in vascular smooth muscle cells from hypertensive rats.
Journal of cardiovascular pharmacology 2007;49(6):346-54.
2007: Ebrahimian Talin; He Ying; Schiffrin Ernesto L; Touyz Rhian M
Differential regulation of thioredoxin and NAD(P)H oxidase by angiotensin II in male and female mice.
Journal of hypertension 2007;25(6):1263-71.
2007: Savoia Carmine; Schiffrin Ernesto L
Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions.
Clinical science (London, England : 1979) 2007;112(7):375-84.
2007: De Ciuceis C; Amiri F; Iglarz M; Cohn J S; Touyz R M; Schiffrin E L
Synergistic vascular protective effects of combined low doses of PPARalpha and PPARgamma activators in angiotensin II-induced hypertension in rats.
British journal of pharmacology 2007;151(1):45-53.
2007: Ko Eun A; Amiri Farhad; Pandey Nihar R; Javeshghani Danesh; Leibovitz Eyal; Touyz Rhian M; Schiffrin Ernesto L
Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: evidence from m-CSF-deficient mice.
American journal of physiology. Heart and circulatory physiology 2007;292(4):H1789-95.
2007: Savoia Carmine; Touyz Rhian M; Volpe Massimo; Schiffrin Ernesto L
Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients.
Hypertension 2007;49(2):341-6.
2007: Sampaio Walkyria Oliveira; Souza dos Santos Robson Augusto; Faria-Silva Raphael; da Mata Machado Leonor Tapias; Schiffrin Ernesto L; Touyz Rhian M
Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways.
Hypertension 2007;49(1):185-92.
2007: Savoia Carmine; Schiffrin Ernesto L
Reduction of C-reactive protein and the use of anti-hypertensives.
Vascular health and risk management 2007;3(6):975-83.
2006: Savoia Carmine; Ebrahimian Talin; He Ying; Gratton Jean-Philippe; Schiffrin Ernesto L; Touyz Rhian M
Angiotensin II/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase.
Journal of hypertension 2006;24(12):2417-22.
2006: Savoia Carmine; Schiffrin Ernesto L
Inhibition of the renin angiotensin system: implications for the endothelium.
Current diabetes reports 2006;6(4):274-8.
2006: Savoia Carmine; Touyz Rhian M; Endemann Dierk H; Pu Qian; Ko Eun A; De Ciuceis Carolina; Schiffrin Ernesto L
Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients.
Hypertension 2006;48(2):271-7.
2006: Javeshghani Danesh; Sairam M Ram; Neves Mario Fritsch; Schiffrin Ernesto L; Touyz Rhian M
Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension.
Journal of hypertension 2006;24(7):1365-73.
2006: Touyz Rhian M; Schiffrin Ernesto L
Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
Vascular pharmacology 2006;45(1):19-28.
2006: Hemmelgarn B R; McAlister Finlay A; Grover Steven; Myers Martin G; McKay Donald W; Bolli Peter; Abbott Carl; Schiffrin Ernesto L; Honos George; Burgess Ellen; Mann Karen; Wilson Thomas; Penner Brian; Tremblay Guy; Milot Alain; Chockalingam Arun; Touyz Rhian M; Tobe Sheldon W;
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.
The Canadian journal of cardiology 2006;22(7):573-81.
2006: White Michel; Ducharme Anique; Ibrahim Reda; Whittom Lucette; Lavoie Joel; Guertin Marie-Claude; Racine Normand; He Ying; Yao Guoying; Rouleau Jean L; Schiffrin Ernesto L; Touyz Rhian M
Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support.
Clinical science (London, England : 1979) 2006;110(4):483-9.
2006: Savoia Carmine; Schiffrin Ernesto L
Inflammation in hypertension.
Current opinion in nephrology and hypertension 2006;15(2):152-8.
2006: Schiffrin Ernesto L
Effects of aldosterone on the vasculature.
Hypertension 2006;47(3):312-8.
2006: Benkirane Karim; Viel Emilie C; Amiri Farhad; Schiffrin Ernesto L
Peroxisome proliferator-activated receptor gamma regulates angiotensin II-stimulated phosphatidylinositol 3-kinase and mitogen-activated protein kinase in blood vessels in vivo.
Hypertension 2006;47(1):102-8.
2006: Brassard Pascal; Amiri Farhad; Thibault Gaétan; Schiffrin Ernesto L
Role of angiotensin type-1 and angiotensin type-2 receptors in the expression of vascular integrins in angiotensin II-infused rats.
Hypertension 2006;47(1):122-7.
2006: Benkirane Karim; Amiri Farhad; Diep Quy N; El Mabrouk Mohammed; Schiffrin Ernesto L
PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1.
American journal of physiology. Heart and circulatory physiology 2006;290(1):H390-7.
2006: Smith Ronald D; Yokoyama Hiroshi; Averill David B; Cooke Lori; Brosnihan K Bridget; Schiffrin Ernesto L; Ferrario Carlos M
The protective effects of angiotensin II blockade with olmesartan medoxomil on resistance vessel remodeling (The VIOS study): rationale and baseline characteristics.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2006;6(5):335-42.
2005: Neves Mario Fritsch; Amiri Farhad; Virdis Agostino; Diep Quy N; Schiffrin Ernesto L;
Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
Canadian journal of physiology and pharmacology 2005;83(11):999-1006.
2005: Tabet Fatiha; Schiffrin Ernesto L; Touyz Rhian M
Mitogen-activated protein kinase activation by hydrogen peroxide is mediated through tyrosine kinase-dependent, protein kinase C-independent pathways in vascular smooth muscle cells: upregulation in spontaneously hypertensive rats.
Journal of hypertension 2005;23(11):2005-12.
2005: Callera Glaucia E; Montezano Augusto C I; Yogi Alvaro; Tostes Rita C; He Ying; Schiffrin Ernesto L; Touyz Rhian M
c-Src-dependent nongenomic signaling responses to aldosterone are increased in vascular myocytes from spontaneously hypertensive rats.
Hypertension 2005;46(4):1032-8.
2005: De Ciuceis Carolina; Amiri Farhad; Brassard Pascal; Endemann Dierk H; Touyz Rhian M; Schiffrin Ernesto L
Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(10):2106-13.
2005: Schiffrin Ernesto L
Blood pressure lowering in PROGRESS (Perindopril Protection Against Recurrent Stroke Study) and white matter hyperintensities: should this progress matter to patients?
Circulation 2005;112(11):1525-6.
2005: Brassard Pascal; Amiri Farhad; Schiffrin Ernesto L
Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries.
Hypertension 2005;46(3):598-606.
2005: Schiffrin Ernesto L
More evidence of cardiorenal protective effects of peroxisome proliferator-activated receptor activation.
Hypertension 2005;46(2):267-8.
2005: Yokoyama Hiroshi; Averill David B; Brosnihan K Bridget; Smith Ronald D; Schiffrin Ernesto L; Ferrario Carlos M
Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy.
American journal of hypertension 2005;18(7):922-9.
2005: Hemmelgarn Brenda R; McAllister Finlay A; Myers Martin G; McKay Donald W; Bolli Peter; Abbott Carl; Schiffrin Ernesto L; Grover Steven; Honos George; Lebel Marcel; Mann Karen; Wilson Thomas; Penner Brian; Tremblay Guy; Tobe Sheldon W; Feldman Ross D;
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk.
The Canadian journal of cardiology 2005;21(8):645-56.
2005: Schiffrin Ernesto L
Vascular endothelin in hypertension.
Vascular pharmacology 2005;43(1):19-29.
2005: Savoia Carmine; Tabet Fatiha; Yao Guoying; Schiffrin Ernesto L; Touyz Rhian M
Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats.
Journal of hypertension 2005;23(5):1037-45.
2005: Callera Glaucia E; Touyz Rhian M; Tostes Rita C; Yogi Alvaro; He Ying; Malkinson Sam; Schiffrin Ernesto L
Aldosterone activates vascular p38MAP kinase and NADPH oxidase via c-Src.
Hypertension 2005;45(4):773-9.
2005: Touyz R M; Yao G; Quinn M T; Pagano P J; Schiffrin E L
p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(3):512-8.
2005: Schiffrin Ernesto L
Peroxisome proliferator-activated receptors and cardiovascular remodeling.
American journal of physiology. Heart and circulatory physiology 2005;288(3):H1037-43.
2005: Schiffrin Ernesto L; Touyz Rhian M
Calcium, magnesium, and oxidative stress in hyperaldosteronism.
Circulation 2005;111(7):830-1.
2005: Pu Qian; Amiri Farhad; Gannon Philippe; Schiffrin Ernesto L
Dual angiotensin-converting enzyme/neutral endopeptidase inhibition on cardiac and renal fibrosis and inflammation in DOCA-salt hypertensive rats.
Journal of hypertension 2005;23(2):401-9.
2005: Touyz Rhian M; Yao Guoying; Schiffrin Ernesto L
Role of the actin cytoskeleton in angiotensin II signaling in human vascular smooth muscle cells.
Canadian journal of physiology and pharmacology 2005;83(1):91-7.
2005: Cruzado Montserrat C; Risler Norma R; Miatello Roberto M; Yao Guoying; Schiffrin Ernesto L; Touyz Rhian M
Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation.
American journal of hypertension 2005;18(1):81-7.
2005: Deanfield John; Donald Ann; Ferri Claudio; Giannattasio Cristina; Halcox Julian; Halligan Sean; Lerman Amir; Mancia Giuseppe; Oliver James J; Pessina Achille C; Rizzoni Damiano; Rossi Gian Paolo; Salvetti Antonio; Schiffrin Ernesto L; Taddei Stefano; Webb David J;
Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension.
Journal of hypertension 2005;23(1):7-17.
2004: Schiffrin Ernesto L
Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment.
American journal of hypertension 2004;17(12 Pt 1):1192-200.
2004: Schiffrin Ernesto L
Vascular stiffening and arterial compliance. Implications for systolic blood pressure.
American journal of hypertension 2004;17(12 Pt 2):39S-48S.
2004: Diep Quy N; Amiri Farhad; Benkirane Karim; Paradis Pierre; Schiffrin Ernesto L
Long-term effects of the PPAR gamma activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive rats.
Canadian journal of physiology and pharmacology 2004;82(11):976-85.
2004: Amiri Farhad; Virdis Agostino; Neves Mario Fritsch; Iglarz Marc; Seidah Nabil G; Touyz Rhian M; Reudelhuber Timothy L; Schiffrin Ernesto L
Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction.
Circulation 2004;110(15):2233-40.
2004: Touyz R M; Schiffrin E L
Reactive oxygen species in vascular biology: implications in hypertension.
Histochemistry and cell biology 2004;122(4):339-52.
2004: Endemann Dierk H; Schiffrin Ernesto L
Endothelial dysfunction.
Journal of the American Society of Nephrology : JASN 2004;15(8):1983-92.
2004: Schiffrin Ernesto L; Touyz Rhian M
From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension.
American journal of physiology. Heart and circulatory physiology 2004;287(2):H435-46.
2004: Tabet Fatiha; Savoia Carmine; Schiffrin Ernesto L; Touyz Rhian M
Differential calcium regulation by hydrogen peroxide and superoxide in vascular smooth muscle cells from spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 2004;44(2):200-8.
2004: Iglarz Marc; Touyz Rhian M; Viel Emilie C; Amiri Farhad; Schiffrin Ernesto L
Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system.
American journal of hypertension 2004;17(7):597-603.
2004: Touyz Rhian M; Yao Guoying; Viel Emilie; Amiri Farhad; Schiffrin Ernesto L
Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells.
Journal of hypertension 2004;22(6):1141-9.
2004: Endemann Dierk H; Touyz Rhian M; Iglarz Marc; Savoia Carmine; Schiffrin Ernesto L
Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
Hypertension 2004;43(6):1252-7.
2004: Neves Mario F; Endemann Dierk; Amiri Farhad; Virdis Agostino; Pu Qian; Rozen Rima; Schiffrin Ernesto L
Small artery mechanics in hyperhomocysteinemic mice: effects of angiotensin II.
Journal of hypertension 2004;22(5):959-66.
2004: Schiffrin Ernesto L
The many targets of aldosterone.
Hypertension 2004;43(5):938-40.
2004: El Mabrouk Mohammed; Diep Quy N; Benkirane Karim; Touyz Rhian M; Schiffrin Ernesto L
SAM68: a downstream target of angiotensin II signaling in vascular smooth muscle cells in genetic hypertension.
American journal of physiology. Heart and circulatory physiology 2004;286(5):H1954-62.
2004: Endemann Dierk H; Schiffrin Ernesto L
Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus.
Current hypertension reports 2004;6(2):85-9.
2004: Callera Glaucia E; Montezano Augusto C; Touyz Rhian M; Zorn Telma M T; Carvalho Maria Helena C; Fortes Zuleica B; Nigro Dorothy; Schiffrin Ernesto L; Tostes Rita C
ETA receptor mediates altered leukocyte-endothelial cell interaction and adhesion molecules expression in DOCA-salt rats.
Hypertension 2004;43(4):872-9.
2004: Elijovich Fernando; Laffer Cheryl L; Schiffrin Ernesto L; Gavras Haralambos; Amador Elias
Endothelin-aldosterone interaction and proteinuria in low-renin hypertension.
Journal of hypertension 2004;22(3):573-82.
2004: Virdis Agostino; Neves Mario Fritsch; Amiri Farhad; Touyz Rhian M; Schiffrin Ernesto L
Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice.
Journal of hypertension 2004;22(3):535-42.
2004: Hermann Frank; Ruschitzka Frank T; Schiffrin Ernesto L
Clinical trials report. CHARM-Preserved Trial.
Current hypertension reports 2004;6(1):48-50.
2004: Hermann Frank; Ruschitzka Frank T; Schiffrin Ernesto L
Clinical trials report. CHARM-Added Trial.
Current hypertension reports 2004;6(1):47.
2004: Hermann Frank; Ruschitzka Frank T; Schiffrin Ernesto L
Clinical trials report. CHARM-Alternative Trial.
Current hypertension reports 2004;6(1):47.
2004: Hermann Frank; Ruschitzka Frank T; Schiffrin Ernesto L
Clinical trials report. CHARM-Overall Programme.
Current hypertension reports 2004;6(1):46.
2004: Hermann Frank; Ruschitzka Frank T; Schiffrin Ernesto L
Clinical trials report. The sweet secret of dark chocolate.
Current hypertension reports 2004;6(1):45-6.
2004: Diep Quy N; Benkirane Karim; Amiri Farhad; Cohn Jeffrey S; Endemann Dierk; Schiffrin Ernesto L
PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats.
Journal of molecular and cellular cardiology 2004;36(2):295-304.
2004: Endemann Dierk H; Pu Qian; De Ciuceis Carolina; Savoia Carmine; Virdis Agostino; Neves Mario F; Touyz Rhian M; Schiffrin Ernesto L
Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment.
Hypertension 2004;43(2):399-404.
2004: Hemmelgarn Brenda R; Zarnke Kelly B; Campbell Norman R C; Feldman Ross D; McKay Donald W; McAlister Finlay A; Khan Nadia; Schiffrin Ernesto L; Myers Martin G; Bolli Peter; Honos George; Lebel Marcel; Levine Mitchell; Padwal Raj;
The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.
The Canadian journal of cardiology 2004;20(1):31-40.
2004: Savoia Carmine; Schiffrin Ernesto L
Significance of recently identified peptides in hypertension: endothelin, natriuretic peptides, adrenomedullin, leptin.
The Medical clinics of North America 2004;88(1):39-62.
2003: Schiffrin Ernesto L
The angiotensin-endothelin relationship: does it play a role in cardiovascular and renal pathophysiology?
Journal of hypertension 2003;21(12):2245-7.
2003: Touyz Rhian M; Tabet Fatiha; Schiffrin Ernesto L
Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension.
Clinical and experimental pharmacology & physiology 2003;30(11):860-6.
2003: Pu Qian; Larouche Isabelle; Schiffrin Ernesto L
Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats.
American journal of hypertension 2003;16(11 Pt 1):931-7.
2003: Callera Glaucia E; Touyz Rhian M; Teixeira Simone A; Muscara Marcelo N; Carvalho Maria Helena C; Fortes Zuleica B; Nigro Dorothy; Schiffrin Ernesto L; Tostes Rita C
ETA receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension.
Hypertension 2003;42(4):811-7.
2003: Javeshghani Danesh; Touyz Rhian M; Sairam M Ram; Virdis Agostino; Neves Mario Fritsch; Schiffrin Ernesto L
Attenuated responses to angiotensin II in follitropin receptor knockout mice, a model of menopause-associated hypertension.
Hypertension 2003;42(4):761-7.
2003: Schiffrin Ernesto L; Amiri Farhad; Benkirane Karim; Iglarz Marc; Diep Quy N
Peroxisome proliferator-activated receptors: vascular and cardiac effects in hypertension.
Hypertension 2003;42(4):664-8.
2003: Iglarz Marc; Touyz Rhian M; Viel Emilie C; Paradis Pierre; Amiri Farhad; Diep Quy N; Schiffrin Ernesto L
Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension.
Hypertension 2003;42(4):737-43.
2003: Schiffrin Ernesto L; Touyz Rhian M
Multiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockade.
Journal of the American College of Cardiology 2003;42(5):911-3.
2003: Virdis Agostino; Iglarz Marc; Neves Mario Fritsch; Amiri Farhad; Touyz Rhian M; Rozen Rima; Schiffrin Ernesto L
Effect of hyperhomocystinemia and hypertension on endothelial function in methylenetetrahydrofolate reductase-deficient mice.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(8):1352-7.
2003: Pu Qian; Neves Mario Fritsch; Virdis Agostino; Touyz Rhian M; Schiffrin Ernesto L
Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling.
Hypertension 2003;42(1):49-55.
2003: Touyz Rhian M; Schiffrin Ernesto L
Role of endothelin in human hypertension.
Canadian journal of physiology and pharmacology 2003;81(6):533-41.
2003: Moreau Pierre; Schiffrin Ernesto L
Role of endothelins in animal models of hypertension: focus on cardiovascular protection.
Canadian journal of physiology and pharmacology 2003;81(6):511-21.
2003: Ruilope Luis M; Segura Julian; Schiffrin Ernesto L
ACE inhibition or angiotensin receptor blockade: which should we use in diabetic patients?
Journal of the renin-angiotensin-aldosterone system : JRAAS 2003;4(2):74-9.
2003: Touyz R M; Yao G; Schiffrin E L
c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(6):981-7.
2003: Schiffrin Ernesto L; Touyz Rhian M
Inflammation and vascular hypertrophy induced by angiotensin II: role of NADPH oxidase-derived reactive oxygen species independently of blood pressure elevation?
Arteriosclerosis, thrombosis, and vascular biology 2003;23(5):707-9.
2003: Iglarz Marc; Schiffrin Ernesto L
Role of endothelin-1 in hypertension.
Current hypertension reports 2003;5(2):144-8.
2003: Douglas Janice G; Bakris George L; Epstein Murray; Ferdinand Keith C; Ferrario Carlos; Flack John M; Jamerson Kenneth A; Jones Wendell E; Haywood Julian; Maxey Randall; Ofili Elizabeth O; Saunders Elijah; Schiffrin Ernesto L; Sica Domenic A; Sowers James R; Vidt Donald G;
Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks.
Archives of internal medicine 2003;163(5):525-41.
2003: Virdis Agostino; Schiffrin Ernesto L
Vascular inflammation: a role in vascular disease in hypertension?
Current opinion in nephrology and hypertension 2003;12(2):181-7.
2003: Schiffrin Ernesto L
Effect of antihypertensive treatment on small artery remodeling in hypertension.
Canadian journal of physiology and pharmacology 2003;81(2):168-76.
2003: Touyz Rhian M; Cruzado Montserrat; Tabet Fatiha; Yao Guoying; Salomon Steven; Schiffrin Ernesto L
Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation.
Canadian journal of physiology and pharmacology 2003;81(2):159-67.
2003: Fritsch Neves Mario; Schiffrin Ernesto L
Aldosterone: a risk factor for vascular disease.
Current hypertension reports 2003;5(1):59-65.
2003: Neves Mario Fritsch; Virdis Agostino; Schiffrin Ernesto L
Resistance artery mechanics and composition in angiotensin II-infused rats: effects of aldosterone antagonism.
Journal of hypertension 2003;21(1):189-98.
2003: Iglarz Marc; Touyz Rhian M; Amiri Farhad; Lavoie Marie-France; Diep Quy N; Schiffrin Ernesto L
Effect of peroxisome proliferator-activated receptor-alpha and -gamma activators on vascular remodeling in endothelin-dependent hypertension.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(1):45-51.
2002: Diep Quy N; Amiri Farhad; Touyz Rhian M; Cohn Jeffrey S; Endemann Dierk; Neves Mario Fritsch; Schiffrin Ernesto L
PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation.
Hypertension 2002;40(6):866-71.
2002: Schiffrin Ernesto L
Vascular and cardiac benefits of angiotensin receptor blockers.
The American journal of medicine 2002;113(5):409-18.
2002: Schiffrin Ernesto L;
Beyond blood pressure: the endothelium and atherosclerosis progression.
American journal of hypertension 2002;15(10 Pt 2):115S-122S.
2002: Virdis Agostino; Neves Mario Fritsch; Amiri Farhad; Viel Emilie; Touyz Rhian M; Schiffrin Ernesto L
Spironolactone improves angiotensin-induced vascular changes and oxidative stress.
Hypertension 2002;40(4):504-10.
2002: Virdis Agostino; Schiffrin Ernesto L
Low birth weight and insulin resistance: can capillary recruitment predict hypertension development?
Journal of hypertension 2002;20(10):1933-5.
2002: Tostes Rita C A; Touyz Rhian M; He Gang; Chen Xin; Schiffrin Ernesto L
Contribution of endothelin-1 to renal activator protein-1 activation and macrophage infiltration in aldosterone-induced hypertension.
Clinical science (London, England : 1979) 2002;103 Suppl 48():25S-30S.
2002: Endemann Dierk; Touyz Rhian M; Yao Guoying; Schiffrin Ernesto L
Tyrosine kinase inhibition attenuates vasopressin-induced contraction of mesenteric resistance arteries: alterations in spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 2002;40(1):123-32.
2002: McAlister Finlay A; Zarnke Kelly B; Campbell Norman R C; Feldman Ross D; Levine Mitchell; Mahon Jeff; Grover Steven A; Lewanczuk Richard; Leenen Frans; Tobe Sheldon; Lebel Marcel; Stone James; Schiffrin Ernesto L; Rabkin Simon W; Ogilvie Richard I; Larochelle Pierre; Jones Charlotte; Honos George; Fodor George; Burgess Ellen; Hamet Pavel; Herman Robert; Irvine Jane; Culleton Bruce; Wright James M;
The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy.
The Canadian journal of cardiology 2002;18(6):625-41.
2002: Zarnke Kelly B; McAlister Finlay A; Campbell Norman R C; Levine Mitchell; Schiffrin Ernesto L; Grover Steven; McKay Donald W; Myers Martin G; Wilson Thomas W; Rabkin Simon W; Feldman Ross D; Burgess Ellen; Bolli Peter; Honos George; Lebel Marcel; Mann Karen; Abbott Carl; Tobe Sheldon; Petrella Robert; Touyz Rhian M;
The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification.
The Canadian journal of cardiology 2002;18(6):604-24.
2002: Touyz Rhian M; Chen Xin; Tabet Fatiha; Yao Guoying; He Gang; Quinn Mark T; Pagano Patrick J; Schiffrin Ernesto L
Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II.
Circulation research 2002;90(11):1205-13.
2002: Touyz Rhian M; Deschepper Christian; Park Jeong Bae; He Gang; Chen Xin; Neves Mario Fritsch T; Virdis Agostino; Schiffrin Ernesto L
Inhibition of mitogen-activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats.
Journal of hypertension 2002;20(6):1127-34.
2002: Tostes Rita C A; Touyz Rhian M; He Gang; Ammarguellat Fatima; Schiffrin Ernesto L
Endothelin A receptor blockade decreases expression of growth factors and collagen and improves matrix metalloproteinase-2 activity in kidneys from stroke-prone spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 2002;39(6):892-900.
2002: Schiffrin Ernesto L
Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers.
The Canadian journal of cardiology 2002;18 Suppl A():15A-18A.
2002: Pu Qian; Touyz Rhian M; Schiffrin Ernesto L
Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats.
Journal of hypertension 2002;20(5):899-907.
2002: Diep Quy N; El Mabrouk Mohammed; Cohn Jeffrey S; Endemann Dierk; Amiri Farhad; Virdis Agostino; Neves Mario Fritsch; Schiffrin Ernesto L
Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma.
Circulation 2002;105(19):2296-302.
2002: Diep Quy N; El Mabrouk Mohammed; Yue Ping; Schiffrin Ernesto L
Effect of AT(1) receptor blockade on cardiac apoptosis in angiotensin II-induced hypertension.
American journal of physiology. Heart and circulatory physiology 2002;282(5):H1635-41.
2002: Schiffrin Ernesto L
Good news for patients with type 2 diabetes: angiotensin receptor blocker treatment delays progression of diabetic nephropathy.
Current opinion in nephrology and hypertension 2002;11(2):173-5.
2002: Ammarguellat Fatima Z; Gannon Philippe O; Amiri Farhad; Schiffrin Ernesto L
Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ET(A) receptors.
Hypertension 2002;39(2 Pt 2):679-84.
2002: Touyz Rhian M; Wu Xiao-Hua; He Gang; Salomon Steven; Schiffrin Ernesto L
Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats.
Hypertension 2002;39(2 Pt 2):479-85.
2002: Park Jeong Bae; Schiffrin Ernesto L
Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1.
American journal of hypertension 2002;15(2 Pt 1):164-9.
2002: Schiffrin Ernesto L; Pu Qian; Park Jeong Bae
Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients.
American journal of hypertension 2002;15(2 Pt 1):105-10.
2002: Schiffrin Ernesto L
Vascular smooth muscle growth and extracellular matrix deposition: is there a role for the sympathetic nervous system?
Journal of hypertension 2002;20(2):179-81.
2002: Schiffrin Ernesto L
Progress in secondary prevention of stroke with PROGRESS. The perindopril protection against recurrent stroke study.
Current hypertension reports 2002;4(1):39-40.
2002: Park Jeong Bae; Touyz Rhian M; Chen Xin; Schiffrin Ernesto L
Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats.
American journal of hypertension 2002;15(1 Pt 1):78-84.
2002: Schiffrin Ernesto L; Park Jeong Bae; Pu Qian
Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function.
Journal of hypertension 2002;20(1):71-8.
2001: Schiffrin E L
A critical review of the role of endothelial factors in the pathogenesis of hypertension.
Journal of cardiovascular pharmacology 2001;38 Suppl 2():S3-6.
2001: Pu Q; Schiffrin E L
Effect of ACE/NEP inhibition on cardiac and vascular collagen in stroke-prone spontaneously hypertensive rats.
American journal of hypertension 2001;14(10):1067-72.
2001: Chen X; Touyz R M; Park J B; Schiffrin E L
Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR.
Hypertension 2001;38(3 Pt 2):606-11.
2001: Ruilope L M; Schiffrin E L
Blood pressure control and benefits of antihypertensive therapy: does it make a difference which agents we use?
Hypertension 2001;38(3 Pt 2):537-42.
2001: Schiffrin E L
Effects of antihypertensive drugs on vascular remodeling: do they predict outcome in response to antihypertensive therapy?
Current opinion in nephrology and hypertension 2001;10(5):617-24.
2001: Diep Q N; Schiffrin E L
Increased expression of peroxisome proliferator-activated receptor-alpha and -gamma in blood vessels of spontaneously hypertensive rats.
Hypertension 2001;38(2):249-54.
2001: Touyz R M; He G; Wu X H; Park J B; Mabrouk M E; Schiffrin E L
Src is an important mediator of extracellular signal-regulated kinase 1/2-dependent growth signaling by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients.
Hypertension 2001;38(1):56-64.
2001: Touyz R M; Schiffrin E L
Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways.
Journal of hypertension 2001;19(7):1245-54.
2001: El Mabrouk M; Touyz R M; Schiffrin E L
Differential ANG II-induced growth activation pathways in mesenteric artery smooth muscle cells from SHR.
American journal of physiology. Heart and circulatory physiology 2001;281(1):H30-9.
2001: Schiffrin E L
Role of endothelin-1 in hypertension and vascular disease.
American journal of hypertension 2001;14(6 Pt 2):83S-89S.
2001: Park J B; Schiffrin E L
ET(A) receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats.
Hypertension 2001;37(6):1444-9.
2001: Park J B; Schiffrin E L
Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension.
Journal of hypertension 2001;19(5):921-30.
2001: Touyz R M; He G; El Mabrouk M; Diep Q; Mardigyan V; Schiffrin E L
Differential activation of extracellular signal-regulated protein kinase 1/2 and p38 mitogen activated-protein kinase by AT1 receptors in vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats.
Journal of hypertension 2001;19(3 Pt 2):553-9.
2001: Touyz R M; Wu X H; He G; Park J B; Chen X; Vacher J; Rajapurohitam V; Schiffrin E L
Role of c-Src in the regulation of vascular contraction and Ca2+ signaling by angiotensin II in human vascular smooth muscle cells.
Journal of hypertension 2001;19(3):441-9.
2001: Park J B; Charbonneau F; Schiffrin E L
Correlation of endothelial function in large and small arteries in human essential hypertension.
Journal of hypertension 2001;19(3):415-20.
2001: Diep Q N; El Mabrouk M; Touyz R M; Schiffrin E L
Expression of cell cycle proteins in blood vessels of angiotensin II-infused rats: role of AT(1) receptors.
Hypertension 2001;37(2 Part 2):604-8.
2001: Touyz R M; He G; El Mabrouk M; Schiffrin E L
p38 Map kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY.
Hypertension 2001;37(2 Part 2):574-80.
2001: Ammarguellat F; Larouche I; Schiffrin E L
Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism.
Circulation 2001;103(2):319-24.
2001: Elijovich F; Laffer C L; Amador E; Gavras H; Bresnahan M R; Schiffrin E L
Regulation of plasma endothelin by salt in salt-sensitive hypertension.
Circulation 2001;103(2):263-8.
2000: Diep Q N; Touyz R M; Schiffrin E L
Docosahexaenoic acid, a peroxisome proliferator-activated receptor-alpha ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase.
Hypertension 2000;36(5):851-5.
2000: Touyz R M; Turgeon A; Schiffrin E L
Endothelin-A-receptor blockade improves renal function and doubles the lifespan of stroke-prone spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 2000;36(5 Suppl 1):S300-4.
2000: Park J B; Schiffrin E L
Effects of antihypertensive therapy on hypertensive vascular disease.
Current hypertension reports 2000;2(3):280-8.
2000: Intengan H D; Schiffrin E L
Vasopeptidase inhibition has potent effects on blood pressure and resistance arteries in stroke-prone spontaneously hypertensive rats.
Hypertension 2000;35(6):1221-5.
2000: Intengan H D; Schiffrin E L
Disparate effects of carvedilol versus metoprolol treatment of stroke-prone spontaneously hypertensive rats on endothelial function of resistance arteries.
Journal of cardiovascular pharmacology 2000;35(5):763-8.
2000: Schiffrin E L; Park J B; Intengan H D; Touyz R M
Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan.
Circulation 2000;101(14):1653-9.
2000: Fareh J; Touyz R M; Schiffrin E L; Thibault G
Altered cardiac endothelin receptors and protein kinase C in deoxycorticosterone-salt hypertensive rats.
Journal of molecular and cellular cardiology 2000;32(4):665-76.
2000: Park J B; Intengan H D; Schiffrin E L
Reduction of resistance artery stiffness by treatment with the AT(1)-receptor antagonist losartan in essential hypertension.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2000;1(1):40-5.
2000: Schiffrin E L
HOPE gives reason for hope. Heart Outcomes Prevention Evaluation.
Current hypertension reports 2000;2(1):59-61.
2000: Diep Q N; Intengan H D; Schiffrin E L
Endothelin-1 attenuates omega3 fatty acid-induced apoptosis by inhibition of caspase 3.
Hypertension 2000;35(1 Pt 2):287-91.
2000: Schiffrin E L
Endothelin: role in experimental hypertension.
Journal of cardiovascular pharmacology 2000;35(4 Suppl 2):S33-35.
1999: Intengan H D; Thibault G; Li J S; Schiffrin E L
Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats : effects of angiotensin receptor antagonism and converting enzyme inhibition.
Circulation 1999;100(22):2267-75.
1999: Touyz R M; Schiffrin E L
Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells.
Hypertension 1999;34(4 Pt 2):976-82.
1999: Intengan H D; Park J B; Schiffrin E L
Blood pressure and small arteries in DOCA-salt-treated genetically AVP-deficient rats: role of endothelin.
Hypertension 1999;34(4 Pt 2):907-13.
1999: Schiffrin E L
State-of-the-Art lecture. Role of endothelin-1 in hypertension.
Hypertension 1999;34(4 Pt 2):876-81.
1999: Larouche I; Schiffrin E L
Cardiac microvasculature in DOCA-salt hypertensive rats : effect of endothelin ET(A) receptor antagonism.
Hypertension 1999;34(4 Pt 2):795-801.
1999: Diep Q N; Li J S; Schiffrin E L
In vivo study of AT(1) and AT(2) angiotensin receptors in apoptosis in rat blood vessels.
Hypertension 1999;34(4 Pt 1):617-24.
1999: Touyz R M; Schiffrin E L
Activation of the Na(+)-H+ exchanger modulates angiotensin II-stimulated Na(+)-dependent Mg2+ transport in vascular smooth muscle cells in genetic hypertension.
Hypertension 1999;34(3):442-9.
1999: Touyz R M; Deng L Y; He G; Wu X H; Schiffrin E L
Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases.
Journal of hypertension 1999;17(7):907-16.
1999: Endemann D; Touyz R M; Li J S; Deng L Y; Schiffrin E L
Altered angiotensin II-induced small artery contraction during the development of hypertension in spontaneously hypertensive rats.
American journal of hypertension 1999;12(7):716-23.
1999: Schiffrin E L; Deng L Y
Relationship between small-artery structure and systolic, diastolic and pulse pressure in essential hypertension.
Journal of hypertension 1999;17(3):381-7.
1999: Touyz R M; El Mabrouk M; He G; Wu X H; Schiffrin E L
Mitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates angiotensin II-mediated signaling and contraction in spontaneously hypertensive rat vascular smooth muscle cells.
Circulation research 1999;84(5):505-15.
1999: Intengan H D; Deng L Y; Li J S; Schiffrin E L
Mechanics and composition of human subcutaneous resistance arteries in essential hypertension.
Hypertension 1999;33(1 Pt 2):569-74.
1999: Touyz R M; Endemann D; He G; Li J S; Schiffrin E L
Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR.
Hypertension 1999;33(1 Pt 2):366-72.
1999: Touyz R M; He G; Deng L Y; Schiffrin E L
Role of extracellular signal-regulated kinases in angiotensin II-stimulated contraction of smooth muscle cells from human resistance arteries.
Circulation 1999;99(3):392-9.
1998: Intengan H D; Schiffrin E L
Mechanical properties of mesenteric resistance arteries from Dahl salt-resistant and salt-sensitive rats: role of endothelin-1.
Journal of hypertension 1998;16(12 Pt 2):1907-12.
1998: Intengan H D; He G; Schiffrin E L
Effect of vasopressin antagonism on structure and mechanics of small arteries and vascular expression of endothelin-1 in deoxycorticosterone acetate salt hypertensive rats.
Hypertension 1998;32(4):770-7.
1998: Sharifi A M; Schiffrin E L
Apoptosis in vasculature of spontaneously hypertensive rats: effect of an angiotensin converting enzyme inhibitor and a calcium channel antagonist.
American journal of hypertension 1998;11(9):1108-16.
1998: Li J S; Turgeon A; Schiffrin E L
Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
American journal of hypertension 1998;11(5):554-62.
1998: Sharifi A M; Li J S; Endemann D; Schiffrin E L
Effects of enalapril and amlodipine on small-artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats.
Journal of hypertension 1998;16(4):457-66.
1998: Touyz R M; Laurant P; Schiffrin E L
Effect of magnesium on calcium responses to vasopressin in vascular smooth muscle cells of spontaneously hypertensive rats.
The Journal of pharmacology and experimental therapeutics 1998;284(3):998-1005.
1998: Li J S; Touyz R M; Schiffrin E L
Effects of AT1 and AT2 angiotensin receptor antagonists in angiotensin II-infused rats.
Hypertension 1998;31(1 Pt 2):487-92.
1998: Schiffrin E L; Touyz R M
Vascular biology of endothelin.
Journal of cardiovascular pharmacology 1998;32 Suppl 3():S2-13.
1998: Schiffrin E L
Endothelin: role in hypertension.
Biological research 1998;31(3):199-208.
1998: Deng L Y; Schiffrin E L
Endothelin-1 gene expression in blood vessels and kidney of spontaneously hypertensive rats (SHR), L-NAME-treated SHR, and renovascular hypertensive rats.
Journal of cardiovascular pharmacology 1998;31 Suppl 1():S380-3.
1998: Sharifi A M; He G; Touyz R M; Schiffrin E L
Vascular endothelin-1 expression and effect of an endothelin ETA antagonist on structure and function of small arteries from stroke-prone spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 1998;31 Suppl 1():S309-12.
1998: Touyz R M; Fareh J; Thibault G; Schiffrin E L
Endothelin-1 signaling is altered in cardiac cells from deoxycorticosterone acetate-salt hypertensive rats.
Journal of cardiovascular pharmacology 1998;31 Suppl 1():S179-81.
1997: Sharifi A M; Schiffrin E L
Apoptosis in aorta of deoxycorticosterone acetate-salt hypertensive rats: effect of endothelin receptor antagonism.
Journal of hypertension 1997;15(12 Pt 1):1441-8.
1997: Touyz R M; Schiffrin E L
Role of calcium influx and intracellular calcium stores in angiotensin II-mediated calcium hyper-responsiveness in smooth muscle from spontaneously hypertensive rats.
Journal of hypertension 1997;15(12 Pt 1):1431-9.
1997: Touyz R M; Schiffrin E L
Growth factors mediate intracellular signaling in vascular smooth muscle cells through protein kinase C-linked pathways.
Hypertension 1997;30(6):1440-7.
1997: Fareh J; Touyz R M; Schiffrin E L; Thibault G
Cardiac type-1 angiotensin II receptor status in deoxycorticosterone acetate-salt hypertension in rats.
Hypertension 1997;30(5):1253-9.
1997: Touyz R M; Schiffrin E L
Angiotensin II regulates vascular smooth muscle cell pH, contraction, and growth via tyrosine kinase-dependent signaling pathways.
Hypertension 1997;30(2 Pt 1):222-9.
1997: Lacroix A; Tremblay J; Touyz R M; Deng L Y; Lariviere R; Cusson J R; Schiffrin E L; Hamet P
Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension.
The Journal of clinical endocrinology and metabolism 1997;82(8):2414-22.
1997: Li J S; Sharifi A M; Schiffrin E L
Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR.
Journal of cardiovascular pharmacology 1997;30(1):75-83.
1997: Schiffrin E L; Intengan H D; Thibault G; Touyz R M
Clinical significance of endothelin in cardiovascular disease.
Current opinion in cardiology 1997;12(4):354-67.
1997: Schiffrin E L; Turgeon A; Deng L Y
Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
British journal of pharmacology 1997;121(5):935-40.
1997: Schiffrin E L; Hayoz D
How to assess vascular remodelling in small and medium-sized muscular arteries in humans.
Journal of hypertension 1997;15(6):571-84.
1997: Elijovich F; Laffer C L; Schiffrin E L
The effects of atenolol and zofenopril on plasma atrial natriuretic peptide are due to their interactions with target organ damage of essential hypertensive patients.
Journal of human hypertension 1997;11(5):313-9.
1997: Touyz R M; Picard S; Schiffrin E L; Deschepper C F
Cyclic GMP inhibits a pharmacologically distinct Na+/H+ exchanger variant in cultured rat astrocytes via an extracellular site of action.
Journal of neurochemistry 1997;68(4):1451-61.
1997: Schiffrin E L; Deng L Y; Sventek P; Day R
Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension.
Journal of hypertension 1997;15(1):57-63.
1997: Li J S; Schiffrin E L
Effect of short-term treatment of SHR with the novel calcium channel antagonist mibefradil on function of small arteries.
American journal of hypertension 1997;10(1):94-100.
1997: Sventek P; Turgeon A; Schiffrin E L
Vascular endothelin-1 gene expression and effect on blood pressure of chronic ETA endothelin receptor antagonism after nitric oxide synthase inhibition with L-NAME in normal rats.
Circulation 1997;95(1):240-4.
1997: Schiffrin E L
Structure and function of small arteries of essential hypertensive patients following chronic treatment with once-a-day nifedipine.
Cardiology 1997;88 Suppl 3():20-6.
1996: Li J S; Sventek P; Schiffrin E L
Effect of antihypertensive treatment and N omega-nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats.
Journal of hypertension 1996;14(11):1331-9.
1996: Touyz R M; Fareh J; Thibault G; Schiffrin E L
Intracellular Ca2+ modulation by angiotensin II and endothelin-1 in cardiomyocytes and fibroblasts from hypertrophied hearts of spontaneously hypertensive rats.
Hypertension 1996;28(5):797-805.
1996: Schiffrin E L; Deng L Y
Structure and function of resistance arteries of hypertensive patients treated with a beta-blocker or a calcium channel antagonist.
Journal of hypertension 1996;14(10):1247-55.
1996: Touyz R M; Schiffrin E L
Angiotensin II and vasopressin modulate intracellular free magnesium in vascular smooth muscle cells through Na+-dependent protein kinase C pathways.
The Journal of biological chemistry 1996;271(40):24353-8.
1996: Singh A; Sventek P; Larivière R; Thibault G; Schiffrin E L
Inducible nitric oxide synthase in vascular smooth muscle cells from prehypertensive spontaneously hypertensive rats.
American journal of hypertension 1996;9(9):867-77.
1996: Sharifi A M; Schiffrin E L
Endothelin receptors mediating vasoconstriction in rat pressurized small arteries.
Canadian journal of physiology and pharmacology 1996;74(8):934-9.
1996: Touyz R M; Deng L Y; Li J S; Schiffrin E L
Differential effects of vasopressin and endothelin-1 on vascular contractile and calcium responses in pressurized small arteries from spontaneously hypertensive rats.
Journal of hypertension 1996;14(8):983-91.
1996: Deng L Y; Day R; Schiffrin E L
Localization of sites of enhanced expression of endothelin-1 in the kidney of DOCA-salt hypertensive rats.
Journal of the American Society of Nephrology : JASN 1996;7(8):1158-64.
1996: Li J S; Schürch W; Schiffrin E L
Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats.
American journal of hypertension 1996;9(8):803-11.
1996: Li J S; Deng L Y; Grove K; Deschepper C F; Schiffrin E L
Comparison of effect of endothelin antagonism and angiotensin-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with N omega-nitro-L-arginine methyl ester. Correlation with topography of vascular endothelin-1 gene expression.
Hypertension 1996;28(2):188-95.
1996: Li J S; Schiffrin E L
Effect of calcium channel blockade or angiotensin-converting enzyme inhibition on structure of coronary, renal, and other small arteries in spontaneously hypertensive rats.
Journal of cardiovascular pharmacology 1996;28(1):68-74.
1996: Li J S; Knafo L; Turgeon A; Garcia R; Schiffrin E L
Effect of endothelin antagonism on blood pressure and vascular structure in renovascular hypertensive rats.
The American journal of physiology 1996;271(1 Pt 2):H88-93.
1996: Marcil J; Schiffrin E L; Anand-Srivastava M B
Aberrant adenylyl cyclase/cAMP signal transduction and G protein levels in platelets from hypertensive patients improve with antihypertensive drug therapy.
Hypertension 1996;28(1):83-90.
1996: Yang X P; Touyz R M; Nguyen P V; Deng L Y; Li J S; Schiffrin E L
Endothelin-1 and vasopressin signalling in blood vessels of young SHR in comparison to adult SHR.
Hypertension research : official journal of the Japanese Society of Hypertension 1996;19(2):121-32.
1996: Schiffrin E L; Larivière R; Li J S; Sventek P
Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure.
Journal of vascular research 1996;33(3):235-48.
1996: Touyz R M; Schiffrin E L
Tyrosine kinase signaling pathways modulate angiotensin II-induced calcium ([Ca2+]i) transients in vascular smooth muscle cells.
Hypertension 1996;27(5):1097-103.
1996: Touyz R M; Sventek P; Larivière R; Thibault G; Fareh J; Reudelhuber T; Schiffrin E L
Cytosolic calcium changes induced by angiotensin II in neonatal rat atrial and ventricular cardiomyocytes are mediated via angiotensin II subtype 1 receptors.
Hypertension 1996;27(5):1090-6.
1996: Touyz R M; Fareh J; Thibault G; Tolloczko B; Larivière R; Schiffrin E L
Modulation of Ca2+ transients in neonatal and adult rat cardiomyocytes by angiotensin II and endothelin-1.
The American journal of physiology 1996;270(3 Pt 2):H857-68.
1996: Fareh J; Touyz R M; Schiffrin E L; Thibault G
Endothelin-1 and angiotensin II receptors in cells from rat hypertrophied heart. Receptor regulation and intracellular Ca2+ modulation.
Circulation research 1996;78(2):302-11.
1996: Sventek P; Turgeon A; García R; Schiffrin E L
Vascular and cardiac overexpression of endothelin-1 gene in one-kidney, one clip Goldblatt hypertensive rats but only in the late phase of two-kidney one clip Goldblatt hypertension.
Journal of hypertension 1996;14(1):57-64.
1996: Sventek P; Li J S; Grove K; Deschepper C F; Schiffrin E L
Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats.
Hypertension 1996;27(1):49-55.
1996: Schiffrin E L
Correction of remodeling and function of small arteries in human hypertension by cilazapril, an angiotensin I-converting enzyme inhibitor.
Journal of cardiovascular pharmacology 1996;27 Suppl 2():S13-8.
1995: Schiffrin E L; Lariviere R; Touyz R M
ETA and ETB receptors on vascular smooth muscle cells from mesenteric vessels of spontaneously hypertensive rats.
Clinical and experimental pharmacology & physiology. Supplement 1995;22(1):S193-4.
1995: Schiffrin E L; Lariviere R; Li J S; Sventek P; Touyz R M
Endothelin-1 gene expression and vascular hypertrophy in DOCA-salt hypertension compared to spontaneously hypertensive rats.
Clinical and experimental pharmacology & physiology. Supplement 1995;22(1):S188-90.
1995: Touyz R M; Schiffrin E L
Treatment of non-insulin-dependent diabetic hypertensive patients with Ca2+ channel blockers is associated with increased platelet sensitivity to insulin.
American journal of hypertension 1995;8(12 Pt 1):1214-21.
1995: Fareh J; Touyz R M; Thibault G; Schiffrin E L
Basal and angiotensin II-induced cytosolic free calcium in adult rat cardiomyocytes and fibroblasts after volume overload.
Hypertension 1995;26(6 Pt 2):1149-53.
1995: Touyz R M; Deng L Y; Schiffrin E L
Endothelin subtype B receptor-mediated calcium and contractile responses in small arteries of hypertensive rats.
Hypertension 1995;26(6 Pt 2):1041-5.
1995: Larivière R; Deng L Y; Day R; Sventek P; Thibault G; Schiffrin E L
Increased endothelin-1 gene expression in the endothelium of coronary arteries and endocardium in the DOCA-salt hypertensive rat.
Journal of molecular and cellular cardiology 1995;27(10):2123-31.
1995: Touyz R M; Larivière R; Schiffrin E L
Endothelin receptor subtypes in mesenteric vascular smooth muscle cells of spontaneously hypertensive rats.
Canadian journal of physiology and pharmacology 1995;73(9):1262-73.
1995: Schiffrin E L
Endothelin in hypertension.
Current opinion in cardiology 1995;10(5):485-94.
1995: Schiffrin E L; Sventek P; Li J S; Turgeon A; Reudelhuber T
Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
British journal of pharmacology 1995;115(8):1377-81.
1995: Mercure C; Thibault G; Lussier-Cacan S; Davignon J; Schiffrin E L; Reudelhuber T L
Molecular analysis of human prorenin prosegment variants in vitro and in vivo.
The Journal of biological chemistry 1995;270(27):16355-9.
1995: Schiffrin E L
Endothelin: potential role in hypertension and vascular hypertrophy.
Hypertension 1995;25(6):1135-43.
1995: Li J S; Schiffrin E L
Chronic endothelin receptor antagonist treatment of young spontaneously hypertensive rats.
Journal of hypertension 1995;13(6):647-52.
1995: Deng L Y; Li J S; Schiffrin E L
Endothelium-dependent relaxation of small arteries from essential hypertensive patients: mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneously hypertensive rats.
Clinical science (London, England : 1979) 1995;88(6):611-22.
1995: Deng L Y; Li J S; Schiffrin E L
Endothelin receptor subtypes in resistance arteries from humans and rats.
Cardiovascular research 1995;29(4):532-5.
1995: Touyz R M; Larivière R; Schiffrin E L
Endothelin influences pHi of human platelets through protein kinase C mediated pathways.
Thrombosis research 1995;78(1):55-65.
1995: Schiffrin E L; Larivière R; Li J S; Sventek P; Touyz R M
Deoxycorticosterone acetate plus salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats.
Hypertension 1995;25(4 Pt 2):769-73.
1995: Schiffrin E L; Deng L Y
Comparison of effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients.
Hypertension 1995;25(4 Pt 2):699-703.
1995: Li J S; Schiffrin E L
Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist.
Hypertension 1995;25(4 Pt 1):495-500.
1995: Day R; Larivière R; Schiffrin E L
In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats.
American journal of hypertension 1995;8(3):294-300.
1995: Larivière R; Sventek P; Thibault G; Schiffrin E L
Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan.
Canadian journal of physiology and pharmacology 1995;73(3):390-8.
1995: Touyz R M; Schiffrin E L
Role of protein kinase C in the anti-aggregatory effects of endothelin-1 on human platelets.
Clinical science (London, England : 1979) 1995;88(3):277-83.
1995: Touyz R M; Tolloczko B; Schiffrin E L
Blunted attenuation of angiotensin II-mediated Ca2+ transients by insulin in cultured unpassaged vascular smooth muscle cells from spontaneously hypertensive rats.
American journal of hypertension 1995;8(2):104-12.
1995: Schiffrin E L; Larivière R; Li J S; Sventek P; Touyz R M
Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy.
Journal of cardiovascular pharmacology 1995;26 Suppl 3():S5-8.
1995: Touyz R M; Fareh J; Thibault G; Larivière R; Schiffrin E L
Modulation of Ca2+ transients in neonatal and adult rat cardiomyocytes by endothelin-1.
Journal of cardiovascular pharmacology 1995;26 Suppl 3():S297-9.
1995: Touyz R M; Deng L Y; Schiffrin E L
Ca2+ and contractile responses of resistance vessels of WKY rats and SHR to endothelin-1.
Journal of cardiovascular pharmacology 1995;26 Suppl 3():S193-6.
1995: Larivière R; Sventek P; Schiffrin E L
Expression of endothelin-1 gene in blood vessels of adult spontaneously hypertensive rats.
Life sciences 1995;56(22):1889-96.
1995: Schiffrin E L
Remodeling of resistance arteries in human hypertension: effects of cilazapril, an angiotensin-I-converting enzyme inhibitor.
Cardiology 1995;86 Suppl 1():16-22.
1994: Schiffrin E L
The endothelium and control of blood vessel function in health and disease.
Clinical and investigative medicine. Médecine clinique et experimentale 1994;17(6):602-20.
1994: Touyz R M; Schiffrin E L
Blunted inhibition by insulin of agonist-stimulated calcium, pH and aggregatory responses in platelets from hypertensive patients.
Journal of hypertension 1994;12(11):1255-63.
1994: Li J S; Schiffrin E L
Resistance artery structure and neuroeffector mechanisms in hypertension induced by inhibition of nitric oxide synthase.
American journal of hypertension 1994;7(11):996-1004.
1994: Li J S; Larivière R; Schiffrin E L
Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.
Hypertension 1994;24(2):183-8.
1994: Schiffrin E L
Intracellular signal transduction for vasoactive peptides in hypertension.
Canadian journal of physiology and pharmacology 1994;72(8):954-62.
1994: Schiffrin E L; Deng L Y; Larochelle P
[Prospective study of the effects of an angiotensin converting enzyme inhibitor and a beta blockader on the structure and function of resistant arteries in mild essential hypertension]
Archives des maladies du coeur et des vaisseaux 1994;87(8):979-81.
1994: Touyz R M; Schiffrin E L
Insulin-induced Ca2+ transport is altered in vascular smooth muscle cells of spontaneously hypertensive rats.
Hypertension 1994;23(6 Pt 2):931-5.
1994: Deschepper C F; Li J S; Schiffrin E L; Welner S A
Hypertension induced by brain grafts from fetal spontaneously hypertensive rats.
Hypertension 1994;23(6 Pt 1):765-73.
1994: Touyz R M; Tolloczko B; Schiffrin E L
Mesenteric vascular smooth muscle cells from spontaneously hypertensive rats display increased calcium responses to angiotensin II but not to endothelin-1.
Journal of hypertension 1994;12(6):663-73.
1994: Schiffrin E L; Deng L Y; Larochelle P
Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension.
Hypertension 1994;23(1):83-91.
1994: Touyz R M; Tolloczko B; Schiffrin E L
Insulin attenuates agonist-evoked calcium transients in vascular smooth muscle cells.
Hypertension 1994;23(1 Suppl):I25-8.
1994: Schiffrin E L; Deng L Y; Larochelle P
Effects of antihypertensive treatment on vascular remodeling in essential hypertensive patients.
Journal of cardiovascular pharmacology 1994;24 Suppl 3():S51-6.
1993: Touyz R M; Schiffrin E L
Effects of angiotensin II and endothelin-1 on platelet aggregation and cytosolic pH and free Ca2+ concentrations in essential hypertension.
Hypertension 1993;22(6):853-62.
1993: Nguyen P V; Yang X P; Li G; Deng L Y; Flückiger J P; Schiffrin E L
Contractile responses and signal transduction of endothelin-1 in aorta and mesenteric vasculature of adult spontaneously hypertensive rats.
Canadian journal of physiology and pharmacology 1993;71(7):473-83.
1993: Larivière R; Day R; Schiffrin E L
Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats.
Hypertension 1993;21(6 Pt 2):916-20.
1993: Schiffrin E L; Deng L Y; Larochelle P
Morphology of resistance arteries and comparison of effects of vasoconstrictors in mild essential hypertensive patients.
Clinical and investigative medicine. Médecine clinique et experimentale 1993;16(3):177-86.
1993: Touyz R M; Schiffrin E L
The effect of angiotensin II on platelet intracellular free magnesium and calcium ionic concentrations in essential hypertension.
Journal of hypertension 1993;11(5):551-8.
1993: Deng L Y; Schiffrin E L
Effect of antihypertensive treatment on response to endothelin of resistance arteries of hypertensive rats.
Journal of cardiovascular pharmacology 1993;21(5):725-31.
1993: Deng L Y; Thibault G; Schiffrin E L
Effect of hypertension induced by nitric oxide synthase inhibition on structure and function of resistance arteries in the rat.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1993;15(3):527-37.
1993: Larivière R; Thibault G; Schiffrin E L
Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats.
Hypertension 1993;21(3):294-300.
1992: Garcia R; Bonhomme M C; Schiffrin E L
Divergent regulation of atrial natriuretic factor receptors in high-output heart failure.
The American journal of physiology 1992;263(6 Pt 2):H1790-7.
1992: Parent A; Nguyen P V; Yang X P; Schiffrin E L
Inositol phosphate production in response to [Arg8]vasopressin, endothelin 1, and prostaglandin F2 alpha in rat aorta and mesenteric arteries.
Canadian journal of physiology and pharmacology 1992;70(10):1408-16.
1992: Schiffrin E L; Parent A; St Louis J; Tremblay J; Garcia R; Thibault G
Vascular atrial natriuretic factor receptors in spontaneously hypertensive rats.
Cardiovascular research 1992;26(9):857-64.
1992: Deng L Y; Schiffrin E L
Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats.
The American journal of physiology 1992;262(6 Pt 2):H1782-7.
1992: Flückiger J P; Nguyen P V; Li G; Yang X P; Schiffrin E L
Calcium, phosphoinositide, and 1,2-diacylglycerol responses of blood vessels of deoxycorticosterone acetate-salt hypertensive rats to endothelin-1.
Hypertension 1992;19(6 Pt 2):743-8.
1992: Schiffrin E L
Reactivity of small blood vessels in hypertension: relation with structural changes. State of the art lecture.
Hypertension 1992;19(2 Suppl):II1-9.
1992: Nguyen P V; Parent A; Deng L Y; Flückiger J P; Thibault G; Schiffrin E L
Endothelin vascular receptors and responses in deoxycorticosterone acetate-salt hypertensive rats.
Hypertension 1992;19(2 Suppl):II98-104.
1991: Gauquelin G; Schiffrin E L; Garcia R
Downregulation of glomerular and vascular atrial natriuretic factor receptor subtypes by angiotensin II.
Journal of hypertension 1991;9(12):1151-60.
1991: Deng L Y; Schiffrin E L
Morphological and functional alterations of mesenteric small resistance arteries in early renal hypertension in rats.
The American journal of physiology 1991;261(4 Pt 2):H1171-7.
1991: Schiffrin E L; Carrier F; Thibault G; Deslongchamps M
Solubilization and molecular characterization of the atrial natriuretic peptide (ANP) receptor in human platelets: comparison with ANP receptors in rat tissues.
The Journal of clinical endocrinology and metabolism 1991;72(2):484-91.
1991: Parent A; Schiffrin E L; St-Louis J
Receptors for Arg8-vasopressin, angiotensin II, and atrial natriuretic peptide in the mesenteric vasculature of pregnant rats.
Canadian journal of physiology and pharmacology 1991;69(2):137-44.
1991: Schiffrin E L; Turgeon A; Tremblay J; Deslongchamps M
Effects of ANP, angiotensin, vasopressin, and endothelin on ANP receptors in cultured rat vascular smooth muscle cells.
The American journal of physiology 1991;260(1 Pt 2):H58-65.
1990: Cachofeiro V; Schiffrin E L; Bonhomme M C; Cantin M; Garcia R
In vivo heterologous regulation of rat glomerular and vascular atrial natriuretic factor receptors by angiotensin II.
Journal of hypertension 1990;8(12):1077-83.
1990: Cachofeiro V; Schiffrin E L; Cantin M; Garcia R
Glomerular and vascular atrial natriuretic factor receptors in cardiomyopathic hamsters: correlation with the peptide biological effects.
Cardiovascular research 1990;24(10):843-50.
1990: Parent A; Schiffrin E L; St-Louis J
Role of the endothelium in adrenergic responses of mesenteric artery rings of pregnant rats.
American journal of obstetrics and gynecology 1990;163(1 Pt 1):229-34.
1990: Nuglozeh E; Gauquelin G; Garcia R; Tremblay J; Schiffrin E L
Atrial natriuretic peptide receptors in renal papilla of DOCA-salt hypertensive rats.
The American journal of physiology 1990;259(1 Pt 2):F130-7.
1990: Massicotte G; Coderre L; Chiasson J L; Thibault G; Schiffrin E L; St-Louis J
Regulation of ANG II and AVP receptors in isolated hepatocytes of pregnant rats.
The American journal of physiology 1990;258(4 Pt 1):E597-605.
1990: Schiffrin E L
Vascular receptors for atrial natriuretic peptide in hypertension.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1990;17(7):673-6.
1989: Schiffrin E L
Vascular receptors for angiotensin, vasopressin, and atrial natriuretic peptide in experimental hypertension.
Canadian journal of physiology and pharmacology 1989;67(9):1118-23.
1989: Garcia R; Gauquelin G; Thibault G; Cantin M; Schiffrin E L
Glomerular atrial natriuretic factor receptors in spontaneously hypertensive rats.
Hypertension 1989;13(6 Pt 1):567-74.
1989: Cachofeiro V; Schiffrin E L; Cantin M; Garcia R
Glomerular and vascular atrial natriuretic factor receptors in adrenalectomized rats.
The American journal of physiology 1989;256(6 Pt 2):R1250-7.
1989: Cachofeiro V; Schiffrin E L; Thibault G; Cantin M; Garcia R
Effect of a chronic infusion of atrial natriuretic factor on glomerular and vascular receptors in spontaneously hypertensive rats.
Journal of hypertension 1989;7(4):335-42.
1989: Larivière R; Baribeau J; St-Louis J; Schiffrin E L
Vasopressin receptors and inositol trisphosphate production in blood vessels of spontaneously hypertensive rats.
Canadian journal of physiology and pharmacology 1989;67(3):232-9.
1988: Schiffrin E L
Regulation of receptors for atrial natriuretic peptide in the rat and human.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1988;2(4):493-500.
1988: Larivière R; St-Louis J; Schiffrin E L
Vascular vasopressin receptors in renal hypertensive rats.
The American journal of physiology 1988;255(4 Pt 2):H693-8.
1988: Gauquelin G; Thibault G; Cantin M; Schiffrin E L; Garcia R
Glomerular atrial natriuretic factor receptors during rehydration: plasma NH2- and COOH-terminal levels.
The American journal of physiology 1988;255(4 Pt 2):F621-5.
1988: Garcia R; Gauquelin G; Cantin M; Schiffrin E L
Glomerular and vascular atrial natriuretic factor receptors in saralasin-sensitive and -resistant two-kidney, one-clip hypertensive rats.
Circulation research 1988;63(3):563-71.
1988: St-Louis J; Coderre C; Schiffrin E L
Atrial natriuretic peptide interferes with calcium requirements in vascular tissues of the rat.
Canadian journal of physiology and pharmacology 1988;66(7):963-6.
1988: St-Louis J; Schiffrin E L
Vasorelaxant effects of and receptors for atrial natriuretic peptides in the mesenteric artery and aorta of the rat.
Canadian journal of physiology and pharmacology 1988;66(7):951-6.
1988: Gauquelin G; Schiffrin E L; Cantin M; Garcia R
Atrial natriuretic factor: specific binding to renal glomeruli during the development of two-kidney, one clip hypertension in the rat.
Journal of hypertension 1988;6(7):587-92.
1988: Schiffrin E L; St-Louis J; Essiambre R
Platelet binding sites and plasma concentration of atrial natriuretic peptide in patients with essential hypertension.
Journal of hypertension 1988;6(7):565-72.
1988: St-Louis J; Parent A; Gutkowska J; Genest J; Schiffrin E L
Vasorelaxation and vascular binding sites for atrial natriuretic peptide in pregnant rats.
The American journal of physiology 1988;254(6 Pt 2):H1027-33.
1988: Larivière R; St-Louis J; Schiffrin E L
Vascular binding sites and biological activity of vasopressin in DOCA-salt hypertensive rats.
Journal of hypertension 1988;6(3):211-7.
1988: Garcia R; Gauquelin G; Cantin M; Schiffrin E L
Renal glomerular atrial natriuretic factor receptors in one-kidney, one clip rats.
Hypertension 1988;11(2):185-90.
1988: Schiffrin E L
Decreased density of binding sites for atrial natriuretic peptide on platelets of patients with severe congestive heart failure.
Clinical science (London, England : 1979) 1988;74(2):213-8.
1988: Gauquelin G; Garcia R; Carrier F; Cantin M; Gutkowska J; Thibault G; Schiffrin E L
Glomerular ANF receptor regulation during changes in sodium and water metabolism.
The American journal of physiology 1988;254(1 Pt 2):F51-5.
1987: Massicotte G; St-Louis J; Parent A; Schiffrin E L
Decreased in vitro responses to vasoconstrictors during gestation in normotensive and spontaneously hypertensive rats.
Canadian journal of physiology and pharmacology 1987;65(12):2466-71.
1987: Massicotte G; St-Louis J; Schiffrin E L
Heart rate reflex responses during gestation in normotensive and spontaneously hypertensive rats following angiotensin II and vasopressin.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1987;186(3):294-8.
1987: Cantin M; Garcia R; Thibault G; Kuchel O; Gutkowska J; Larochelle P; Hamet P; Schiffrin E L; Genest J
Atrial natriuretic factor (ANF) in experimental and human hypertension.
Clinical and investigative medicine. Médecine clinique et experimentale 1987;10(6):561-7.
1986: St-Louis J; Parent A; Larivière R; Schiffrin E L
Vasopressin responses and receptors in the mesenteric vasculature of estrogen-treated rats.
The American journal of physiology 1986;251(5 Pt 2):H885-9.

Sign-in to see more